Skip to main content
Equibles
ANNX logo

ANNX · Annexon, Inc. · Metrics

Track ANNX — free

Use ANNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.86 +0.03 (+0.78%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$798.36M
Shares
204.44M
Volume · Oct 21 4.95M Avg daily vol (3M) 3.05M

ANNX metrics

59 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.86
Market cap
$798.36M

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
-9.2%
Price change (3M)
-28.9%
Price change (6M)
-38.2%
Price change (YTD)
-23.7%
Price change (1Y)
+21.2%
Trailing year
Price change (5Y)
-80.2%
52-week high
$6.96
52-week low
$2.68
Change from 52-week high
-45.0%
Change from 52-week low
+42.9%
Annualized volatility
76.5%
Annualized volatility (3M)
64.7%
Beta
1.7
RSI (14D)
44.4
Price vs SMA 50
-13.6%
Price vs SMA 200
-27.6%
Avg volume (3M)
3.02M
Relative volume
2.1
Average dollar volume
$13.61M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
204.44M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
4.2
reciprocal yield 23.7%
FCF yield
-24.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-25.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$210.56M
Net income (TTM)
−$202.67M
Trailing 12 months
Diluted EPS (TTM)
$-1.14
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.42

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+35.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-108.9%
Return on assets
-82.4%
Debt / equity
—
Current ratio
5.5
EBITDA (TTM)
—
Free cash flow (TTM)
−$193.22M
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$199.27M
Latest balance sheet
Cash & equivalents
$199.27M
Total assets
$246.07M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$193.03M
Capital expenditures (TTM)
$185,000
R&D (TTM)
$174.74M
SG&A (TTM)
—
Stock compensation (TTM)
$16.11M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
217
13F filer change QoQ
0
Institutional ownership
87.9%
Conviction holders (share of 13F filers)
1.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+10.1%
Holder tenure
13.1
Price vs estimated holder cost
+6.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.7%

Short interest

3 metrics
Short interest
15.7%
Latest settlement · 8.9 days to cover
Days to cover
8.9d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
$99,829
Insider-sentiment score
79 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1528115 CUSIP 03589W102 13F (30d) 15 filings 15 filers Visit website Investor relations